ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 326061 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 326061; 2) Community: the network communities that were significantly associated with the response to NSC 326061; 3) Molecule: the relationships between components within communities and NSC 326061; 4) MDR: the compounds that were significantly associated with the NSC 326061.

NSC Compound Enrichment Correlation
NSC 661421 Null 0.0438391811600409 0.17814689
NSC 681239 Bortezomib 0.0438391811600409 -0.013367183
NSC 683558 Camptothecin Derivative 0.0438391811600409 0.075439571
NSC 724907 8-Chloro-7-cyano-3-(1-naphthylamino)-5,5-dioxo[1,2,4]triazol o[4,3-b][1,4,2]benzodithiazine 0.0438391811600409 0.12418079
NSC 730035 6-amino-5-(4-fluorobenzyl)-7-(1-methyl-1H-benzo[d]imidazol-2 -yl)-5H-pyrrolo[2,3-b]pyrazine-2,3-dicarbonitrile 0.0438391811600409 0.26212458
NSC 731022 Null 0.0438391811600409 -0.085469244
NSC 741567 Null 0.0438391811600409 0.066526115
NSC 757925 3,5-bis(4-hydroxy-3-methoxystyryl)-N-(4-fluorophenyl)-1H-pyrazole-1-carboxamide 0.0438391811600409 0.070789377
NSC 759630 LANATOSIDE C 0.0438391811600409 0.16916983
NSC 760015 E)-1-(4-(quinazolin-4-ylamino)phenyl)-3-(2,4,6-trimethoxyphenyl)prop-2-en-1-one 0.0438391811600409 0.13100409
Total:108  Current:100    [First] [Prev] [Next] [Last]